Can Heparin Plasma Be Used Instead of Serum for Nephelometric Analysis of Serum Proteins?(Letters) (Letter to the Editor)
Clinical Chemistry 2006, August, 52, 8
-
- €2.99
-
- €2.99
Publisher Description
To the Editor: Nephelometry is widely used for quantification of serum proteins. The main manufacturers of nephelometers, Beckman-Coulter and DadeBehring, recommend serum as a sample for most tests. For a limited number of tests, e.g., lipoprotein(a), they state that serum and heparin plasma can be used. Serum should be separated from contact with cells as soon as possible (1), but blood should be allowed to sit long enough for complete clot formation because inadequate clot formation with residual fibrin strands can clog the sampling pipette. Use of plasma circumvents these clotting-related problems. We therefore investigated whether lithium-heparin plasma can be used for nephelometric analysis of a whole array of serum proteins.
Can Whole-Blood Samples Be Stored over 24 Hours Without Compromising Stability of C-Reactive Protein, Retinol, Ferritin, Folic Acid, And Fatty Acids in Epidemiologic Research?(Technical Briefs) (Clinical Report)
2005
Components of Total Measurement Error for Hemoglobin [A.Sub.1C] (Technical Briefs) (Clinical Report)
2001
Interlaboratory Variation of Plasma Total Homocysteine Measurements: Results of Three Successive Homocysteine Proficiency Testing Surveys (General Clinical Chemistry)
2002
Metabolomics in Practice
2013
Molecular Epidemiology of Chronic Diseases
2011
Clinical Proteomics
2008
Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial)
2003